癌症并中性粒细胞减少病人的抗菌药物应用指南[1]

[]2002-08-08[](1962-),(),,[]1671-9638(2002)01-0075-04[1]33(,410008)[];;[]R557+.3R730.5[]A,1/2,1/5100/mm3,,,,,,,11.138.3()38.011.2500/mm3,1000/mm3500/mm3(:2000/mm3;500/mm3[2])1000/mm3,,500/mm31000/mm3,100/mm3500/mm3;,(500/mm310),2;;;()(B2III),,,,,,,,()(),11,500CFU/mm3,,MRSA()PRSP()VRE()5720021011ChinJInfectControlVol1No1Oct2002,,;,,60%70%,/;;;;,33.11(1),,(A2II)(2),,,,3.2+/:100/mm3,100/mm3,X,,7,10,,,,39.0,,,,3.3,,,,(A2I),155354433602:26,21116100/mm3,,,3.4,()3.5,12,;,;:;MRSA;;,(),27(5),2,57,5,,(A2II),,6720021011ChinJInfectControlVol1No1Oct2002(B2II)(A2II)(A2II)JK,,(C2III)144.1352(1),,7,(2),,(3),,48h/,(4)(B2II)2357720021011ChinJInfectControlVol1No1Oct20024.23533(1),;,(2),,(3)5,5-7(),(B2II)3355(4)5.13(1)2500/mm3,,,48h(C2III)(2)7500/mm3,,,57(3),5.23(1)500/mm345(2)500/mm3,2;(3),,4(ANC=)8720021011ChinJInfectControlVol1No1Oct2002:(100/mm3)(C2II),,2(C2III),,,4(C2III)22ABCDE11,;(1);;,,66.1,2,,,,,,6.2(1),,2747000(2)B,BB,,CTBB,,,,,,4,,,57,,B6.3(C2II)6.4,(D2II)6.5,,TMP/SMZ,SMZ/TMP(A21)(D2II),[][1]HughesWT,AmstrongD,BodeyGP,etal.2002guidelinesfortheuseofantimicrobialagentsinneutropenicpatientswithcancer[J].CID,2002,34:730-751.[2].[A]..[M].:,1999.2757-2761.9720021011ChinJInfectControlVol1No1Oct2002